[HTML][HTML] Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil

Q Su, X Lv, Y Sun, Z Ye, B Kong, Z Qin - Biomedicine & Pharmacotherapy, 2018 - Elsevier
Coronary microembolization (CME) is a common complication during the treatment of acute
coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Nicorandil can be …

[HTML][HTML] The mechanism of miR-142-3p in coronary microembolization-induced myocardiac injury via regulating target gene IRAK-1

Q Su, X Lv, Z Ye, Y Sun, B Kong, Z Qin, L Li - Cell Death & Disease, 2019 - nature.com
Coronary microembolization (CME) is a common complication seen during primary
percutaneous coronary intervention (pPCI). CME-induced myocardiac inflammation is the …

Inflammation as a risk factor for stroke in atrial fibrillation: data from a microarray data analysis

Y Li, W Tan, F Ye, S Wen, R Hu, X Cai… - Journal of …, 2020 - journals.sagepub.com
Objective Stroke is a severe complication of atrial fibrillation (AF). We aimed to discover key
genes and microRNAs related to stroke risk in patients with AF using bioinformatics analysis …

[HTML][HTML] Effects of trimetazidine on PDCD4/NF-κB/TNF-α pathway in coronary microembolization

Q Su, L Li, J Zhao, Y Sun, H Yang - Cellular Physiology and …, 2017 - karger.com
Background/Aims: The local inflammatory response caused by coronary microembolization
(CME) is the primary cause of progressive cardiac dysfunction. The PDCD4/NF-κB/TNF-α …

Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention

Q Su, Z Ye, Y Sun, H Yang, L Li - Scandinavian journal of clinical …, 2018 - Taylor & Francis
To investigate the relationship between miRNA-30e level in circulation and no-reflow
phenomenon in patients with acute ST-segment elevation myocardial infarction (STEMI) …

[HTML][HTML] Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury

Q Su, X Lv, Y Sun, H Yang, Z Ye, L Li - Biomedicine & Pharmacotherapy, 2018 - Elsevier
Objective Coronary microembolization (CME) is a common complication in percutaneous
coronary intervention (PCI). Local myocardial inflammation caused by CME is the major …

[HTML][HTML] Resveratrol pretreatment alleviates NLRP3 inflammasome-mediated cardiomyocyte pyroptosis by targeting TLR4/MyD88/NF-κB signaling cascade in …

CJ Luo, T Li, HL Li, Y Zhou, L Li - Korean J Physiol …, 2023 - synapse.koreamed.org
Percutaneous coronary intervention and acute coronary syndrome are both closely tied to
the frequently occurring complication of coronary microembolization (CME). Resveratrol …

Ultrasound-targeted microbubble destruction-mediated microRNA-21 transfection regulated PDCD4/NF-κB/TNF-α pathway to prevent coronary microembolization …

Q Su, L Li, Y Liu, Y Zhou, J Wang, W Wen - Gene therapy, 2015 - nature.com
The programmed cell death 4/nuclear factor-κB/tumor necrosis factor α (PDCD4/NF-κB/TNF-
α) signaling pathway has an important role in coronary microembolization (CME)-induced …

Identification of potentially relevant genes for myocardial infarction using RNA sequencing data analysis

Q Zhao, K Wu, N Li, Z Li, F Jin - Experimental and …, 2018 - spandidos-publications.com
Myocardial infarction (MI) is a heart disease with high morbidity and mortality rates, thus it is
critical to identify genes that serve roles during its pathogenesis. The objective of the present …

Low-intensity focused ultrasound guided dodecafluoropentane-loaded acoustic phase-change nanoparticles for treatment of porcine coronary microthromboembolism

N Jiang, Z Wang, Q Deng, Y Zhou, S Cao… - International Journal of …, 2023 - Elsevier
Background Coronary microthromboembolism after acute myocardial infarction (AMI)
requires urgent and effective treatment. Early and effective recovery of coronary …